Marina Biotech, Inc.Company Review & Valuation

MRNA
OTC Markets

About Marina Biotech, Inc.

Marina Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of proprietary drug therapeutics primarily for hypertension, arthritis, pain, and oncology in the United States, Europe, and internationally. The company offers Prestalia, a single-pill fixed dose comShow morebination (FDC) of perindopril argenine, an angiotensin-converting-enzyme inhibitor; and amlodipine besylate, a calcium channel blocker for the treatment of hypertension. Its clinical development programs include IT-102 and IT-103, a celecoxib program drug candidates for the treatment of combined arthritis pain/hypertension and the treatment of pain requiring a high dose of celecoxib; CEQ508, an oral delivery of small interfering RNA against beta-catenin, combined with IT-102 to suppress polyps in the precancerous syndrome and orphan indication familial adenomatous polyposis; and CEQ508 combined with IT-103 to treat colorectal cancer. The company is headquartered in City of Industry, California.Show less

Industry
Biotechnology
HQ Location
City of Industry, California

Stock Price

Price data not available for Marina Biotech, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

NanoString Technologies
Codexis
Basilea Pharmaceutica
BELLUS Health

back to top